BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

New Food & Drug Law Institute's Food and Drug Policy Forum Focuses on Liability Issues in Vaccine Design Defect Claims


2/8/2011 2:29:41 PM

WASHINGTON, Feb. 8, 2011 /PRNewswire-USNewswire/ -- The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States, assert Daniel J. Gage, Assistant Director and Alison R. Perencevich, Legislative Assistant, at the American Academy of Pediatrics' Department of Federal Affairs.

Writing in the February 8, 2011 issue of FDLI's Food and Drug Policy Forum (Volume 1, Number 3), the authors take a close look at this emerging health care liability question: "Should the National Childhood Vaccine Injury Act of 1986 Allow Families of Children Injured by Vaccines to Sue Manufacturers Directly for Design Defect Claims?"

Gage and Perencevich argue that the Supreme Court should uphold the ruling in Bruesewitz v. Wyeth, Inc. which held that the National Childhood Vaccine Injury Act of 1986 preempts design defect claims. They also recommend that policymakers review the entire statute, which, they maintain, can both protect manufacturers from uncontrolled litigation and compensate families fairly for any injuries caused by defective vaccine. In their article, the authors stress the importance of primary care providers in vaccine administration and suggest that they receive adequate reimbursement for their services.

FDLI's Food and Drug Policy Forum is a twice-a-month, peer-reviewed, digital publication on current food and drug policy topics. Posed in the form of a question, each issue provides subscribers and purchasers with pertinent background information, relevant research, discussion of central issues, relevant resources and policy recommendations. The views, opinions and statements expressed in the Policy Forum are those of the authors. The Food and Drug Law Institute neither contributes to nor endorses Policy Forum articles. As a nonprofit 501 (c) (3) organization, FDLI does not engage in advocacy activities. FDLI welcomes Policy Forum articles from differing perspectives on food and drug issues.

FDLI, founded in 1949, is a non-profit organization that provides a marketplace for discussing food and drug law issues through conferences, publications and member interaction. FDLI's scope includes food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

FDLI members receive the Policy Forum as a benefit of their membership. Non-members may subscribe to the Forum for a fee.

For subscription information or to purchase individual issues of the Policy Forum, visit www.fdli.org.

SOURCE Food and Drug Law Institute



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES